Abstract:Ethyl 3-{2-[(4-cyano-3-fluorophenyl substituent)methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido}propanoate(3a,3e) were prepared by cyclization of ethyl-3-[3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido]propanoate with 2-(4-cyano-3-fluorophenyl substituent)acetic acid. 2-{3-[2-(4-Cyano-3-fluorophenyl substituent)methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido}propanamido substituent(6a~6h) were prepared by hydrolysis and amidation from 3. Eight novel benzoimidazole derivatives(7a~7h) were synthesized by cyclization reaction of 6 with acetomenadione. The structures were characterized by 1H NMR and HR-ESI-MS. The anticoagulant activities of 7a~7h were investigated. The results showed that 7a and 7c exhibited anticoagulant activities. The aPTTs were (83.1±4.2)s and (80.7±2.9)s, respectively, which were better than dabigatran etexilate(75.3±2.1)s.